Fig. 4
From: Radiomic analysis of Gd-EOB-DTPA-enhanced MRI predicts Ki-67 expression in hepatocellular carcinoma
Decision curve analysis of the AP, combined AP and HBP radiomics model in validation cohort. The red line and blue line represent the AP, and combined AP and HBP radiomics model. The decision curve shows that combined AP and HBP radiomics model does not result in extra significant benefits compared with AP radiomics model in validation cohort